Skip to main content Accessibility help
×
Home

Effect of modern surgical treatment on the inflammatory/anti-inflammatory balance in patients with obstructive sleep apnoea

  • M Binar (a1), T M Akcam (a2), O Karakoc (a1), R I Sagkan (a3), U Musabak (a3) and M Gerek (a1)...

Abstract

Objective:

To investigate the inflammatory/anti-inflammatory cytokine balance – T helper 1/T helper 2 ratios – in obstructive sleep apnoea patients, before and after treatment.

Methods:

Twenty-eight patients received continuous positive airway pressure treatment and 29 patients who could not tolerate continuous positive airway pressure were scheduled for surgery. Serum levels of interleukins 2, 4 and 10, tumour necrosis factor-alpha, and interferon gamma were analysed by enzyme-linked immunosorbent assays before and three months after treatment.

Results:

The success rate of surgical treatment was 65.5 per cent. Mean compliance for the continuous positive airway pressure group was 40.9 per cent. The apnoea/hypopnoea index significantly decreased in both groups after treatment (p < 0.001). The interferon gamma/interleukin-4 ratio decreased following surgical treatment (p = 0.014), and the interleukin-2/interleukin-4 ratio decreased after treatment in 57 patients in the overall cohort (p = 0.032).

Conclusion:

After treatment for obstructive sleep apnoea, some ratios reflecting T helper 1/T helper 2 cytokine balance favoured the T helper 2 direction, suggesting a shift to an anti-inflammatory state. Successful surgery and better continuous positive airway pressure compliance can help ameliorate inflammation in obstructive sleep apnoea patients, which may reduce associated morbidities.

Copyright

Corresponding author

Address for correspondence: Dr Murat Binar, Gulhane Egitim Arastırma Hastanesi, KBB AD, Etlik, 06018, Kecioren, Ankara, Turkey Fax: +90 312 304 5700 E-mail: mbinar4@yahoo.com

Footnotes

Hide All

Presented at the 26th Congress of the European Rhinologic Society, in conjunction with the 35th Congress of the International Society of Inflammation and 17th Congress of the International Rhinologic Society (‘ERS-ISIAN-IRS 2016 Congress’), 3–7 July 2016, Stockholm, Sweden.

Footnotes

References

Hide All
1 Garvey, JF, Taylor, CT, McNicholas, WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009;33:1195–205
2 Dempsey, JA, Veasey, SC, Morgan, BJ, O'Donnell, CP. Pathophysiology of sleep apnea. Physiol Rev 2010;90:47112
3 Semenza, GL. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res 2001;49:614–17
4 Htoo, AK, Greenberg, H, Tongia, S, Chen, G, Henderson, T, Wilson, D et al. Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 2006;10:4350
5 Ryan, S, Taylor, CT, McNicholas, WT. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 2009;64:631–6
6 Nadeem, R, Molnar, J, Madbouly, EM, Nida, M, Aggarwal, S, Sajid, H et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 2013;9:1003–12
7 Yokoe, T, Minoguchi, K, Matsuo, H, Oda, N, Minoguchi, H, Yoshino, G et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129–34
8 Vgontzas, AN, Papanicolaou, DA, Bixler, EO, Kales, A, Tyson, K, Chrousos, GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313–16
9 Kataoka, T, Enomoto, F, Kim, R, Yokoi, H, Fujimori, M, Sakai, Y et al. The effect of surgical treatment of obstructive sleep apnea syndrome on the plasma TNF-alpha levels. Tohoku J Exp Med 2004;204:267–72
10 Swain, SL, Bradley, LM, Croft, M, Tonkonogy, S, Atkins, G, Weinberg, AD et al. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev 1991;123:115–44
11 Girón-González, JA, Moral, FJ, Elvira, J, García-Gil, D, Guerrero, F, Gavilán, I et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000;143:31–6
12 Arias, MA, García-Río, F, Alonso-Fernández, A, Hernanz, A, Hidalgo, R, Martínez-Mateo, V et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 2008;32:1009–15
13 Kohler, M, Ayers, L, Pepperell, JC, Packwood, KL, Ferry, B, Crosthwaite, N et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 2009;64:6773
14 Wu, KM, Lin, CC, Chiu, CH, Liaw, SF. Effect of treatment by nasal continuous positive airway pressure on serum high mobility group box-1 protein in obstructive sleep apnea. Chest 2010;137:303–9
15 Jullian-Desayes, I, Joyeux-Faure, M, Tamisier, R, Launois, S, Borel, AL, Levy, P et al. Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials. Sleep Med Rev 2015;21:2338
16 Xie, X, Pan, L, Ren, D, Du, C, Guo, Y. Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med 2013;14:1139–50
17 Ishida, K, Kato, M, Kato, Y, Yanagihara, K, Kinugasa, Y, Kotani, K et al. Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest 2009;136:125–9
18 Ip, MS, Lam, B, Chan, LY, Zheng, L, Tsang, KW, Fung, PC et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166–71
19 Harsch, IA, Konturek, PC, Koebnick, C, Kuehnlein, PP, Fuchs, FS, Pour Schahin, S et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003;22:251–7
20 Guo, Y, Pan, L, Ren, D, Xie, X. Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 2013;17:495503
21 Baessler, A, Nadeem, R, Harvey, M, Madbouly, E, Younus, A, Sajid, H et al. Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers – a meta-analysis . J Inflamm (Lond) 2013;10:13
22 Karamanlı, H, Özol, D, Ugur, KS, Yıldırım, Z, Armutçu, F, Bozkurt, B et al. Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath 2014;18:251–6
23 Chu, L, Li, Q. The evaluation of adenotonsillectomy on TNF-alpha and IL-6 levels in obese children with obstructive sleep apnea. Int J Pediatr Otorhinolaryngol 2013;77:690–4
24 Constantinidis, J, Ereliadis, S, Angouridakis, N, Konstantinidis, I, Vital, V, Angouridaki, C. Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Otorhinolaryngol 2008;265:1275–9
25 Berry, RB, Budhiraja, R, Gottlieb, DJ, Gozal, D, Iber, C, Kapur, VK et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012;8:597619
26 Calvin, AD, Albuquerque, FN, Lopez-Jimenez, F, Somers, VK. Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord 2009;7:271–8
27 Minoguchi, K, Tazaki, T, Yokoe, T, Minoguchi, H, Watanabe, Y, Yamamoto, M et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004;126:1473–9
28 Ciftci, TU, Kokturk, O, Bukan, N, Bilgihan, A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004;28:8791
29 Alberti, A, Sarchielli, P, Gallinella, E, Floridi, A, Mazzotta, G, Gallai, V. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 2003;12:305–11
30 Vgontzas, AN, Zoumakis, E, Lin, HM, Bixler, EO, Trakada, G, Chrousos, GP. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004;89:4409–13
31 Wagner, H, Hardt, C, Heeg, K, Pfizenmaier, K, Stotter, H, Rollinghoff, M. The in vivo effects of interleukin 2 (TCGF). Immunobiology 1982;161:139–56
32 Sarinc Ulasli, S, Sarıaydın, M, Gunay, E, Halici, B, Celik, S, Koyuncu, T et al. Effects of nondipping pattern on systemic inflammation in obstructive sleep apnea. Sleep Breath 2015;19:1185–90
33 Ransom, J, Fischer, M, Mosmann, T, Yokota, T, DeLuca, D, Schumacher, J et al. Interferon-gamma is produced by activated immature mouse thymocytes and inhibits the interleukin 4-induced proliferation of immature thymocytes. J Immunol 1987;139:4102–8
34 de Waal Malefyt, R, Abrams, J, Bennett, B, Figdor, CG, de Vries, JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209–20
35 Dyugovskaya, L, Lavie, P, Lavie, L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 2005;1051:340–50
36 Heeschen, C, Dimmeler, S, Hamm, CW, Fichtlscherer, S, Boersma, E, Simoons, ML et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003;107:2109–14
37 Potteaux, S, Deleuze, V, Merval, R, Bureau, MF, Esposito, B, Scherman, D et al. In vivo electrotransfer of interleukin-10 cDNA prevents endothelial upregulation of activated NF-kappaB and adhesion molecules following an atherogenic diet. Eur Cytokine Netw 2006;17:1318
38 De Luca Canto, G, Pacheco-Pereira, C, Aydinoz, S, Major, PW, Flores-Mir, C, Gozal, D. Biomarkers associated with obstructive sleep apnea: a scoping review. Sleep Med Rev 2014;23:2845
39 Jiang, H, Cao, H, Wang, P, Liu, W, Cao, F, Chen, J. Tumour necrosis factor-alpha/interleukin-10 ratio in patients with obstructive sleep apnoea hypopnoea syndrome. J Laryngol Otol 2015;129:73–8
40 Billiau, A. Interferons and inflammation. J Interferon Res 1987;7:559–67
41 Gately, MK, Warrier, RR, Honasoge, S, Carvajal, DM, Faherty, DA, Connaughton, SE et al. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int Immunol 1994;6:157–67
42 Tam, CS, Wong, M, McBain, R, Bailey, S, Waters, KA. Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health 2006;42:277–82
43 Waters, KA, Mast, BT, Vella, S, de la Eva, R, O'Brien, LM, Bailey, S et al. Structural equation modeling of sleep apnea, inflammation, and metabolic dysfunction in children. J Sleep Res 2007;16:388–95

Keywords

Effect of modern surgical treatment on the inflammatory/anti-inflammatory balance in patients with obstructive sleep apnoea

  • M Binar (a1), T M Akcam (a2), O Karakoc (a1), R I Sagkan (a3), U Musabak (a3) and M Gerek (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed